Aurora Cannabis (ACB) stock
ACB's Quality Score rose 1 point on Fri, Oct 2, to 5.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Why ACB scores 5
Below AverageTrending up, 4 of 14 checks firingWhat the Quality Score means
- +4Chart checks 4 of 14 firing right now, one point each
- +2Profit Made CA$1.6M in the year to Mar 31, 2025, after a loss of CA$69.3M the year before, from the SEC filing. That is the newest full year on file, 18 months old
- Size subtracts
What's next
Expected to report Wed Nov 4, before the open
What would turn ACB's score around: 4 things, for Pro members
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
ACB has 4 of 14 checks firing
One per group is shown here.
Also on the chart
- RSI 1451.5
- MACD (12, 26, 9)Below signal
- 50-day average$3.65
- 200-day average$3.58
- ADX 1425.3
- Support$3.68
- Resistance$4.13
- Bollinger Bands (20, 2)Inside
- Volume0.8x
How ACB ranks in Pharma
ACB is #21 of 91 by Quality Score. The top three are shown with their scores, and more by name.
ABBV8/1419
GMAB8/1415
MRK7/1413
ABTOpen for its score
ACHVOpen for its score
ALKSOpen for its score
ACB4/145
When does ACB report earnings, and what happens after?
Expected to report Wed Nov 4, before the open (in 30 days). Not yet confirmed by the company.
About Aurora Cannabis
Aurora Cannabis Inc is focused on the production, distribution, and sale of cannabis products in Canada and internationally. The Company conducts the production, distribution, and sale of medical cannabis products and, on a very limited basis, consumer cannabis products in Canada pursuant to the Cannabis Act; the production and distribution of wholesale medical cannabis in the European Union pursuant to the German Medicinal Products Act and German Narcotic Drugs Act; and the distribution of wholesale medical cannabis in various international markets, including Australia and New Zealand. Its segments are Canadian Cannabis CGU, European Cannabis CGU, Australia Cannabis CGU, and New Zealand Cannabis CGU, with Canada generating majority revenue.
Pro members see every line of every stock's score.
- Real-time prices, no delay
- Every line of ACB's score, with the points and the reason
- All 14 checks on ACB and on all 3,243 stocks
- Every stock ranked, with the chart
- Every filing, and optional alerts on ACB
Straight Answers
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.
Where does the data come from?
Daily bars, quotes, reference data, headlines, and short interest come from Massive, formerly Polygon, a licensed market data vendor. The age of the quotes is shown at the top of every page. Insider trades, notable holders and profits come straight from the SEC. That means Form 4 filings, 13F filings and XBRL financial data on EDGAR. Government filings come from the public STOCK Act and Office of Government Ethics disclosures. The market-wide headlines on the market line also come from the public headline feeds CNBC, MarketWatch and Yahoo Finance publish, shown as the headline, the source and a link to the article. Splits, dividends, and the financial statements on each ticker page come from the vendor's reference data. The 8-K filings on EDGAR are read for the items that move a price. Five years of history is loaded for every stock. So the 200-day and 52-week checks rest on real history. Options flow is not part of the product.
Do I need an account?
Not to start. Tap any green button and you're in, free, with no email and no password. To keep going, create a free account with Google, Apple, or your email. There is no password to make up.
Is this investment advice?
No. It is a screening tool that scores stocks on the chart, the company's own results, and the news and filings. It does not know your situation and it is not a recommendation to buy or sell anything. Please do your own research.